Adverse Events During Supervised Exercise Interventions in Pediatric Oncology-A Nationwide Survey

Gauß G, Beller R, Boos J, Däggelmann J, Stalf H, Wiskemann J, Götte M (2021)

In: Frontiers in pediatrics, 9.

Research article (journal)

Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data

Würthwein G, Lanvers-Kaminsky C, Siebel C, Gerß J, Möricke A, Zimmermann M, Stary J, Smisek P, Schrappe M, Rizzari C, Zucchetti M, Hempel G, Wicha SG, Boos J (2021)

In: European Journal of Drug Metabolism and Pharmacokinetics, 46(2).

Research article (journal)

Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

Siebel C, Würthwein G, Lanvers-Kaminsky C, André N, Berthold F, Castelli I, Chastagner P, Doz F, English M, Escherich G, Frühwald MC, Graf N, Groll AH, Ruggiero A, Hempel G, Boos J (2020)

In: BMC pharmacology & toxicology, 21(1).

Research article (journal)

Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study

Würthwein G, Lanvers-Kaminsky C, Gerss J, Möricke A, Zimmermann M, Stary J, Smisek P, Attarbaschi A, Nath C, Zucchetti M, Rizzari C, Schrappe M, Boos J (2020)

In: Therapeutic Drug Monitoring, 42(3).

Research article (journal)

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia

Khalil A, Würthwein G, Golitsch J, Hempel G, Fobker M, Gerss J, Möricke A, Zimmermann M, Smisek P, Zucchetti M, Nath C, Attarbaschi A, Stackelberg A, Gökbuget N, Rizzari C, Conter V, Schrappe M, Boos J, Lanvers-Kaminsky C (2020)

In: Haematologica, Online ahead of print.

Research article (journal)

Publications

Contact

Top-Links

Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach Siebel C, Lanvers-Kaminsky C, Alten J, Smisek P, Nath CE, Rizzari C, Boos J, Würthwein G (2021) In: European Journal of Drug Metabolism and Pharmacokinetics, 2021. Research article (journal)
Adverse Events During Supervised Exercise Interventions in Pediatric Oncology-A Nationwide Survey Gauß G, Beller R, Boos J, Däggelmann J, Stalf H, Wiskemann J, Götte M (2021) In: Frontiers in pediatrics, 9. Research article (journal)
Physical Activity, Exercise and Sports in Young Cancer Patients Götte M, Kesting S, Boos J (2021) In: Beck JD, Bokemeyer C, Langer T (eds.), Late Treatment Effects and Cancer Survivor Care in the Young. . Research article (book contribution)
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data Würthwein G, Lanvers-Kaminsky C, Siebel C, Gerß J, Möricke A, Zimmermann M, Stary J, Smisek P, Schrappe M, Rizzari C, Zucchetti M, Hempel G, Wicha SG, Boos J (2021) In: European Journal of Drug Metabolism and Pharmacokinetics, 46(2). Research article (journal)
Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia Lanvers-Kaminsky C, Niemann A, Eveslage M, Beck J, Köhnke T, Martin S, Wit M, Spriewald B, Hauspurg H, Hoelzer D, Boos J, Gökbuget N (2020) In: Leukemia & lymphoma, 61(1). Research article (journal)
Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure Siebel C, Würthwein G, Lanvers-Kaminsky C, André N, Berthold F, Castelli I, Chastagner P, Doz F, English M, Escherich G, Frühwald MC, Graf N, Groll AH, Ruggiero A, Hempel G, Boos J (2020) In: BMC pharmacology & toxicology, 21(1). Research article (journal)
Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR Berthold F, Faldum A, Ernst A, Boos J, Dilloo D, Eggert A, Fischer M, Frühwald M, Henze G, Klingebiel T, Kratz C, Kremens B, Krug B, Leuschner I, Schmidt M, Schmidt R, Schumacher-Kuckelkorn R, von Schweinitz D, Schilling FH, Theissen J, Volland R, Hero B, Simon T (2020) In: Annals of Oncology, 31(3). Research article (journal)
Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study Würthwein G, Lanvers-Kaminsky C, Gerss J, Möricke A, Zimmermann M, Stary J, Smisek P, Attarbaschi A, Nath C, Zucchetti M, Rizzari C, Schrappe M, Boos J (2020) In: Therapeutic Drug Monitoring, 42(3). Research article (journal)
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoring Siebel C, Lanvers-Kaminsky C, Würthwein G, Hempel G, Boos J (2020) In: Scientific Reports, 10(1). Research article (journal)
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia Khalil A, Würthwein G, Golitsch J, Hempel G, Fobker M, Gerss J, Möricke A, Zimmermann M, Smisek P, Zucchetti M, Nath C, Attarbaschi A, Stackelberg A, Gökbuget N, Rizzari C, Conter V, Schrappe M, Boos J, Lanvers-Kaminsky C (2020) In: Haematologica, Online ahead of print. Research article (journal)